Jane Street’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148K Sell
129,951
-226,843
-64% -$276K ﹤0.01% 10359
2026
Q1
$450K Sell
356,794
-296,980
-45% -$375K ﹤0.01% 8307
2025
Q4
$798K Buy
653,774
+273,447
+72% +$411K ﹤0.01% 6624
2025
Q3
$563K Buy
380,327
+56,915
+18% +$86.8K ﹤0.01% 7603
2025
Q2
$375K Buy
323,412
+186,696
+137% +$264K ﹤0.01% 7442
2025
Q1
$185K Sell
136,716
-45,299
-25% -$275K ﹤0.01% 8506
2024
Q4
$2.4M Sell
182,015
-4,711
-3% -$64.3K ﹤0.01% 3800
2024
Q3
$2.09M Sell
186,726
-50,772
-21% -$635K ﹤0.01% 4381
2024
Q2
$2.55M Buy
237,498
+108,586
+84% +$1.4M ﹤0.01% 4083
2024
Q1
$1.92M Buy
128,912
+39,768
+45% +$656K ﹤0.01% 4205
2023
Q4
$1.61M Buy
89,144
+65,905
+284% +$1M ﹤0.01% 4709
2023
Q3
$403K Sell
23,239
-55,189
-70% -$957K ﹤0.01% 6607
2023
Q2
$1.42M Sell
78,428
-144,102
-65% -$3.41M ﹤0.01% 4667
2023
Q1
$5.92M Buy
222,530
+178,237
+402% +$5.07M ﹤0.01% 2215
2022
Q4
$856K Buy
+44,293
New +$926K ﹤0.01% 5225
2020
Q3
Sell
-13,389
Closed -$435K 7744
2020
Q2
$435K Buy
+13,389
New +$355K ﹤0.01% 5284

Other funds holding PLRX

Jane Street's PLRX Position: Q2 2026 in Review

Jane Street reduced its Pliant Therapeutics (PLRX) stake by 64% in Q2 2026, selling an estimated $276K and leaving 129,951 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #10359.

Jane Street first reported a position in PLRX in Q2 2020 and has held it in 16 quarters since. The position peaked at $5.92M in Q1 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Jane Street held 129,951 shares of Pliant Therapeutics worth $148K as of Q2 2026.
  • Jane Street sold 226,843 Pliant Therapeutics shares in Q2 2026, an estimated $276K.
  • Pliant Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10359 holding.
  • Jane Street first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 16 quarters since.
  • Jane Street's Pliant Therapeutics position peaked at $5.92M in Q1 2023.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.